Effect of Exercise on Prevention of Weight Gain

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00177502
First received: September 12, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

The purpose of this study is to examine the dose-response of exercise on prevention of weight gain in overweight adults.


Condition Intervention Phase
Weight Loss
Behavioral: behavioral exercise intervention
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Effect of Exercise on Prevention of Weight Gain

Resource links provided by NLM:


Further study details as provided by University of Pittsburgh:

Primary Outcome Measures:
  • body weight

Secondary Outcome Measures:
  • fitness
  • physical activity
  • dietary intake
  • mediators

Estimated Enrollment: 294
Study Start Date: January 2003
Estimated Study Completion Date: December 2006
  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Female or Male
  2. 18-55 years of age
  3. BMI = 25-29.9 kg/m2
  4. Ability to provide informed consent.
  5. Ability to provide consent from their personal physician to participate in this study.

Exclusion Criteria:

  1. Reporting regular exercise participation of at least 20 minutes per day on at least 3 days per week during the previous six months. (This study is designed to recruit relatively sedentary adults.)
  2. Diabetes, hypothyroidism, or other medical conditions which would affect energy metabolism.
  3. Women who are currently pregnant, pregnant within the previous six months, or planning on becoming pregnant within the next 12 months. (Pregnancy during initial screening will be based on self-report and will be included on the detailed medical history that is completed by subjects. However, this will be confirmed with the urine pregnancy test that will be conducted prior to the baseline DEXA.)
  4. Non-medicated resting systolic blood pressure >160 mmHg or non-medicated resting diastolic blood pressure >100 mmHg, or taking medication that would affect blood pressure.
  5. Taking medication that would affect resting heart rate or the heart rate response during exercise (e.g., beta blockade).
  6. Arrhythmia on resting or exercise electrocardiogram that would indicate that vigorous exercise was contraindicated.
  7. History of myocardial infarction or valvular disease.
  8. History of orthopedic complications that would prevent optimal participation in the exercise component (e.g., heel spurs, severe arthritis).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00177502

Locations
United States, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15203
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: John M Jakicic, Ph.D. University of Pittsburgh
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00177502     History of Changes
Other Study ID Numbers: R01 HL070257-01A1, R01 HL070257-01A1
Study First Received: September 12, 2005
Last Updated: September 12, 2005
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Weight Gain
Weight Loss
Body Weight Changes
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on July 28, 2014